SCHEMBL2900877

SCHEMBL2900877

Brc1c2ccccc2c(Br)c2cc(-c3cc4ccc5ccccc5c4c4ccccc34)ccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.40
ERBB2 P04626 1/20 0.40
FYN P06241 1/20 0.40
MAOA P21397 1/20 0.40
ACHE P22303 1/20 0.40
AHR P35869 1/20 0.40
POLB P06746 1/20 0.37
HPRT1 P00492 3/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 5/20 0.36
ALDH1A1 P00352 4/20 0.36
TSHR P16473 3/20 0.36
HPGD P15428 3/20 0.36
HIF1A Q16665 3/20 0.36
MAPK1 P28482 2/20 0.36
CASP1 P29466 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12025762 0.81 GRM2 (0.43) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL2903602 0.80 GSTP1 (0.46) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL3421191 0.80 ALDH1A1 (0.30) CYP1A2HSD17B10ALDH1A1HPGDTHRB
SCHEMBL3421194 0.79 ALDH1A1 (0.46) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL13249098 0.79 ALDH1A1 (0.46) CYP1A2POLBHPRT1KDM4EMEN1
SCHEMBL2474235 0.79 MAOA (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL4567309 0.77 ABCG2 (0.44) CYP1A2FYNAHRKDM4EMEN1
SCHEMBL29558179 0.77 CYP1A2 (0.37) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL3420935 0.75 ESR1 (0.48) CYP1A2POLBHPRT1KDM4EMEN1
SCHEMBL12214809 0.75 ALDH1A1 (0.41) CYP1A2ERBB2FYNMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9614159-B2 Benzophenanthrene derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2017-04-04 US disclosed
US-9614159-B2 Benzophenanthrene derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2017-04-04 US disclosed
US-9614159-B2 Benzophenanthrene derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2017-04-04 US disclosed
US-20130285029-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-10-31 US disclosed
US-20130285029-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-10-31 US disclosed
US-20130285029-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-10-31 US disclosed
EP-2218706-B1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO (JP) 2013-08-21 EP disclosed
US-8507106-B2 Benzophenanthrene derivative and organic electroluminescent device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2013-08-13 US disclosed
US-8507106-B2 Benzophenanthrene derivative and organic electroluminescent device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2013-08-13 US disclosed
US-8507106-B2 Benzophenanthrene derivative and organic electroluminescent device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2013-08-13 US disclosed
US-20100320452-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. 2010-12-23 US disclosed
US-20100320452-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. 2010-12-23 US disclosed
US-20100320452-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. 2010-12-23 US disclosed
EP-2218706-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2010-08-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100320452-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME NRAS, RSU1, RAP1A CYP1A2 1816/4885ERBB2 683/4885FYN 2343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.